North of Tyne and Gateshead Diabetic Eye Screening Programme
A Contract Award Notice
by NHS ENGLAND CUMBRIA AND THE NORTH EAST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £3M
- Sector
- HEALTH
- Published
- 25 Mar 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Newcastle upon Tyne
2 buyers
- NHS England Cumbria & the North East Newcastle upon Tyne
1 supplier
- Northgate Public Services Madingley
Description
Contract awarded by NHS England Cumbria and North East. As a result of extreme urgency following COVID-19 pressures, a Single Tender Action has been enacted for a provision of eye screening service to the North of Tyne and Gateshead eligible population, in order to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. The contracting authority intends to undertake a procurement process following the direct award in accordance with the Public Contract Regulations 2015 (as amended) depending upon the outcome of current procurement consultation. Future process will be published via Find a Tender and Contracts Finder.
Total Quantity or Scope
The purpose of the service is to provide an eye screening service to the North of Tyne and Gateshead eligible population, in order to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. The population size is circa seventy thousand.
Award Detail
1 | Northgate Public Services (Madingley)
|
Award Criteria
PRICE | _ |
CPV Codes
- 85000000 - Health and social work services
- 85100000 - Health services
Indicators
- Award on basis of price.
Legal Justification
Due to the unforeseeable, unexpected and continuing impact of COVID-19 upon Diabetic Eye Screening Services that is likely to continue through 2021-22 as the post COVID-19 risks and unintended consequences become known and better understood
Reference
- FTS 006056-2021